Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
tissue plasminogen activator with dual antiplatelet therapy in acute ischemic stroke
IRCT2017082117756N24Phase 2Completed
- Sponsor
- Vice Chancellor for Research, Birjand University of Medical Sciences
- Start
- Mar 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of tissue-plasminogen activator in ischemic stroke, sponsored by Vice Chancellor for Research, Birjand University of Medical Sciences. Started Mar 2017; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on IRCT2017082117756N24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017082117756N24.